X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs NATCO PHARMA - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS NATCO PHARMA NOVARTIS/
NATCO PHARMA
 
P/E (TTM) x 393.4 30.7 1,282.8% View Chart
P/BV x 19.4 23.2 83.4% View Chart
Dividend Yield % 1.5 0.5 302.5%  

Financials

 NOVARTIS   NATCO PHARMA
EQUITY SHARE DATA
    NOVARTIS
Mar-16
NATCO PHARMA
Mar-14
NOVARTIS/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs982877 112.0%   
Low Rs556424 131.3%   
Sales per share (Unadj.) Rs252.9223.4 113.2%  
Earnings per share (Unadj.) Rs62.131.1 200.0%  
Cash flow per share (Unadj.) Rs63.340.3 157.2%  
Dividends per share (Unadj.) Rs10.005.00 200.0%  
Dividend yield (eoy) %1.30.8 169.1%  
Book value per share (Unadj.) Rs363.6219.5 165.7%  
Shares outstanding (eoy) m31.9633.07 96.6%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x3.02.9 104.5%   
Avg P/E ratio x12.420.9 59.1%  
P/CF ratio (eoy) x12.216.1 75.3%  
Price / Book Value ratio x2.13.0 71.4%  
Dividend payout %16.116.1 100.0%   
Avg Mkt Cap Rs m24,58021,504 114.3%   
No. of employees `0000.8NA-   
Total wages/salary Rs m1,8011,128 159.7%   
Avg. sales/employee Rs Th10,748.9NM-  
Avg. wages/employee Rs Th2,395.2NM-  
Avg. net profit/employee Rs Th2,641.1NM-  
INCOME DATA
Net Sales Rs m8,0837,389 109.4%  
Other income Rs m829167 496.3%   
Total revenues Rs m8,9137,556 118.0%   
Gross profit Rs m2341,793 13.1%  
Depreciation Rs m37304 12.1%   
Interest Rs m2366 0.5%   
Profit before tax Rs m1,0251,290 79.5%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m170-   
Extraordinary Inc (Exp) Rs m1,6960-   
Tax Rs m752309 243.6%   
Profit after tax Rs m1,9861,027 193.3%  
Gross profit margin %2.924.3 11.9%  
Effective tax rate %73.423.9 306.5%   
Net profit margin %24.613.9 176.7%  
BALANCE SHEET DATA
Current assets Rs m12,6783,681 344.4%   
Current liabilities Rs m2,4333,123 77.9%   
Net working cap to sales %126.77.6 1,676.6%  
Current ratio x5.21.2 442.0%  
Inventory Days Days3389 36.5%  
Debtors Days Days2259 38.3%  
Net fixed assets Rs m697,685 0.9%   
Share capital Rs m160331 48.3%   
"Free" reserves Rs m11,4606,670 171.8%   
Net worth Rs m11,6217,259 160.1%   
Long term debt Rs m0955 0.0%   
Total assets Rs m14,40011,957 120.4%  
Interest coverage x570.54.5 12,615.8%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.60.6 90.8%   
Return on assets %13.811.7 118.4%  
Return on equity %17.114.2 120.7%  
Return on capital %23.620.7 113.8%  
Exports to sales %0.739.4 1.9%   
Imports to sales %18.65.7 326.1%   
Exports (fob) Rs m602,908 2.1%   
Imports (cif) Rs m1,503421 356.8%   
Fx inflow Rs m1863,445 5.4%   
Fx outflow Rs m1,821703 259.1%   
Net fx Rs m-1,6352,743 -59.6%   
CASH FLOW
From Operations Rs m2,5311,440 175.7%  
From Investments Rs m-8,270-1,089 759.2%  
From Financial Activity Rs m-386-353 109.4%  
Net Cashflow Rs m-6,125-1 411,040.3%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 75.0 1.5 5,102.0%  
Indian inst/Mut Fund % 2.0 7.8 25.5%  
FIIs % 1.6 16.6 9.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 26.0 82.7%  
Shareholders   41,647 25,395 164.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   TTK HEALTHCARE  UNICHEM LAB  WYETH LTD  ELDER PHARMA  ALEMBIC LTD  

Compare NOVARTIS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jan 19, 2018 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS